Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Neurologic Disorders Therapeutics
1.2 Key Market Segments
1.2.1 Neurologic Disorders Therapeutics Segment by Type
1.2.2 Neurologic Disorders Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Neurologic Disorders Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Neurologic Disorders Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Neurologic Disorders Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Neurologic Disorders Therapeutics Market Competitive Landscape
3.1 Global Neurologic Disorders Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Neurologic Disorders Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Neurologic Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neurologic Disorders Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Neurologic Disorders Therapeutics Sales Sites, Area Served, Product Type
3.6 Neurologic Disorders Therapeutics Market Competitive Situation and Trends
3.6.1 Neurologic Disorders Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neurologic Disorders Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Neurologic Disorders Therapeutics Industry Chain Analysis
4.1 Neurologic Disorders Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Neurologic Disorders Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Neurologic Disorders Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neurologic Disorders Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Neurologic Disorders Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Neurologic Disorders Therapeutics Price by Type (2019-2024)
7 Neurologic Disorders Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neurologic Disorders Therapeutics Market Sales by Application (2019-2024)
7.3 Global Neurologic Disorders Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Neurologic Disorders Therapeutics Sales Growth Rate by Application (2019-2024)
8 Neurologic Disorders Therapeutics Market Segmentation by Region
8.1 Global Neurologic Disorders Therapeutics Sales by Region
8.1.1 Global Neurologic Disorders Therapeutics Sales by Region
8.1.2 Global Neurologic Disorders Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Neurologic Disorders Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neurologic Disorders Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neurologic Disorders Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neurologic Disorders Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neurologic Disorders Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Biogen Inc.
9.1.1 Biogen Inc. Neurologic Disorders Therapeutics Basic Information
9.1.2 Biogen Inc. Neurologic Disorders Therapeutics Product Overview
9.1.3 Biogen Inc. Neurologic Disorders Therapeutics Product Market Performance
9.1.4 Biogen Inc. Business Overview
9.1.5 Biogen Inc. Neurologic Disorders Therapeutics SWOT Analysis
9.1.6 Biogen Inc. Recent Developments
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Basic Information
9.2.2 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Product Overview
9.2.3 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Product Market Performance
9.2.4 F. Hoffmann-La Roche Ltd. Business Overview
9.2.5 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics SWOT Analysis
9.2.6 F. Hoffmann-La Roche Ltd. Recent Developments
9.3 Johnson and Johnson Services Inc.
9.3.1 Johnson and Johnson Services Inc. Neurologic Disorders Therapeutics Basic Information
9.3.2 Johnson and Johnson Services Inc. Neurologic Disorders Therapeutics Product Overview
9.3.3 Johnson and Johnson Services Inc. Neurologic Disorders Therapeutics Product Market Performance
9.3.4 Johnson and Johnson Services Inc. Neurologic Disorders Therapeutics SWOT Analysis
9.3.5 Johnson and Johnson Services Inc. Business Overview
9.3.6 Johnson and Johnson Services Inc. Recent Developments
9.4 Novartis AG
9.4.1 Novartis AG Neurologic Disorders Therapeutics Basic Information
9.4.2 Novartis AG Neurologic Disorders Therapeutics Product Overview
9.4.3 Novartis AG Neurologic Disorders Therapeutics Product Market Performance
9.4.4 Novartis AG Business Overview
9.4.5 Novartis AG Recent Developments
9.5 Pfizer Inc.
9.5.1 Pfizer Inc. Neurologic Disorders Therapeutics Basic Information
9.5.2 Pfizer Inc. Neurologic Disorders Therapeutics Product Overview
9.5.3 Pfizer Inc. Neurologic Disorders Therapeutics Product Market Performance
9.5.4 Pfizer Inc. Business Overview
9.5.5 Pfizer Inc. Recent Developments
10 Neurologic Disorders Therapeutics Market Forecast by Region
10.1 Global Neurologic Disorders Therapeutics Market Size Forecast
10.2 Global Neurologic Disorders Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neurologic Disorders Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Neurologic Disorders Therapeutics Market Size Forecast by Region
10.2.4 South America Neurologic Disorders Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neurologic Disorders Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Neurologic Disorders Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Neurologic Disorders Therapeutics by Type (2025-2030)
11.1.2 Global Neurologic Disorders Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Neurologic Disorders Therapeutics by Type (2025-2030)
11.2 Global Neurologic Disorders Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Neurologic Disorders Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Neurologic Disorders Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
